HOXB7 and neoplasm: In the cutaneous squamous cell carcinoma (CSCC) cells, HOXB7 bound to β-catenin, and HOXB7 knockdown reduced cell viability and tumor growth by inhibiting the Wnt/β-catenin signaling pathway48.